FDA recall D-0281-2022

Teligent Pharma, Inc. · Class II · drug

Product

Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL), 50 mL glass bottles, Rx Only, Teligent Pharma Inc., Buena, NJ 08310, NDC 52565-009-50

Reason for recall

CGMP Deviations: Lots recalled because they were manufactured at the same facility using the same components as the products that had cracked seals in caps that were found to be superpotent.

Distribution

Nationwide within the United States

Key facts

Status
Terminated
Initiation date
2021-10-12
Report date
2021-12-22
Termination date
2024-06-18
Voluntary/Mandated
Voluntary: Firm initiated
Location
Buena, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0281-2022